deferoxamine has been researched along with glycerol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Paller, MS | 1 |
| Burkhart, KM; Conrad, DS; Gmur, DJ; Zager, RA | 1 |
| Chander, V; Chopra, K; Singh, D | 1 |
| Constantinescu, I; Hamilton, JL; Horte, S; Imran ul-haq, M; Kizhakkedathu, JN; Lai, BF; Leitch, HA; Shenoi, RA | 1 |
| Abbina, S; Hamilton, JL; Hatef, A; Imran Ul-Haq, M; Kalathottukaren, MT; Kizhakkedathu, JN; Lai, BF; Unniappan, S | 1 |
| Creagh, AL; Hamilton, JL; Haynes, CA; Kizhakkedathu, JN; Ul-Haq, MI | 1 |
| Elliot, MA; Shepherdson, EMF | 1 |
8 other study(ies) available for deferoxamine and glycerol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity.
Topics: Acute Kidney Injury; Animals; Deferoxamine; Disease Models, Animal; Glycerol; Hemoglobins; Iron; Kidney; Lipid Peroxides; Male; Malondialdehyde; Myoglobin; Rats; Rats, Inbred Strains | 1988 |
Iron, heme oxygenase, and glutathione: effects on myohemoglobinuric proximal tubular injury.
Topics: Animals; Cell-Free System; Deferoxamine; Free Radical Scavengers; Glutathione; Glycerol; Heme Oxygenase (Decyclizing); Hydroxyl Radical; Iron; Iron Chelating Agents; Kidney Tubules; Lipid Peroxides; Male; Myoglobinuria; Rats; Rats, Sprague-Dawley; Reference Values | 1995 |
Attenuation of glycerol-induced acute renal failure in rats by trimetazidine and deferoxamine.
Topics: Acute Kidney Injury; Animals; Deferoxamine; Disease Models, Animal; Glycerol; Iron Chelating Agents; Kidney; Kidney Function Tests; Male; Oxidative Stress; Rats; Rats, Wistar; Trimetazidine; Vasodilator Agents | 2003 |
Design of long circulating nontoxic dendritic polymers for the removal of iron in vivo.
Topics: Animals; Biocompatible Materials; Cell Survival; Chelating Agents; Complement Activation; Deferoxamine; Disease Models, Animal; Drug Design; Erythrocytes; Female; Ferritins; Glycerol; Hemolysis; Human Umbilical Vein Endothelial Cells; Humans; Iron; Iron Overload; Mice; Mice, Inbred BALB C; Nanomedicine; Nanotechnology; Partial Thromboplastin Time; Polymers; Prothrombin Time; Thrombelastography; Tissue Distribution | 2013 |
In vivo efficacy, toxicity and biodistribution of ultra-long circulating desferrioxamine based polymeric iron chelator.
Topics: Animals; Deferoxamine; Female; Glycerol; Human Umbilical Vein Endothelial Cells; Humans; Iron Chelating Agents; Iron Overload; Mice; Mice, Inbred BALB C; Polymers; Tissue Distribution; Zebrafish | 2016 |
Iron Binding and Iron Removal Efficiency of Desferrioxamine Based Polymeric Iron Chelators: Influence of Molecular Size and Chelator Density.
Topics: Deferoxamine; Glycerol; Humans; Iron; Iron Chelating Agents; Molecular Weight; Polymers | 2017 |
Cryptic specialized metabolites drive
Topics: Chloramphenicol; Coproporphyrins; Deferoxamine; Glycerol; Iron; Microbial Interactions; Saccharomyces cerevisiae; Siderophores; Streptomyces | 2022 |